A proposed sale to Bayer, antitrust concerns, stockholder value, worries over future use of Roundup in Europe and a failure to be paid for GMO traits by farmers in India and Argentina are major concerns facing executives these days at Monsanto’s headquarters in St. Louis. Unfortunately, few of these situations appear favorable to American farmers who are concerned that the proposed ag chemical company mergers will lead to even higher crop input prices.

A 3-year research study conducted by five U.S. universities and the USDA found that fall armyworms in the southeastern U.S. are developing resistance to genetically modified crops.